0
13

In This Issue
  |  
The American Journal of Psychiatry

September 01, 1986, Vol. 143, No. 9
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Editorial
The doctor-patient covenant and the threat of exploitation
Special Articles
Meyerian psychobiology, personality development, and the role of life experiences
Hallucinations: theoretical and clinical overview
REGULAR ARTICLES
A DSM-III family study of the nonschizophrenic psychotic disorders
Two-year follow-up of exposure and imipramine treatment of agoraphobia
Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures
Spectrum and frequency of use of statistical techniques in psychiatric journals
Psychiatrist-patient sexual contact: results of a national survey. I: Prevalence
Symptom profiles of patients with DSM-III anxiety disorders
Depression and depressive symptoms in preschool children from the general population
Julia Rush's diary: coping with loss in the early nineteenth century
Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression
Outcome study of first-episode psychosis. I: Relapse rates after 1 year
Graft and donor denial in heart transplant recipients
An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms
Effects of lithium carbonate on associative productivity and idiosyncrasy in bipolar outpatients
Exacerbation of schizophrenia associated with amantadine
Agitated depression, alprazolam, and panic anxiety
Pharmacokinetics of desipramine in Caucasian and Asian volunteers
Neuroleptic-induced tics in two hyperactive children
Controversies in Schizophrenia: Changes and Constancies
E. FULLER TORREY
Neurobiology of Periodic Psychoses
CHARLES VANVALKENBURG
The Chronic Mental Patient: Five Years Later
JOHN L. SCHWARTZ
The Long-Term Treatment of Functional Psychoses: Needed Areas of Research
LYNN DELISI
Psychiatry
FREDERICK K. GOODWIN; PETER ROY-BYRNE
General Hospital Psychiatry
DONALD W. BLACK
Psychiatry: The State of the Art
WILLIAM R. YATES
Lost Years: Confessions of a Woman Alcoholic; Alcohol Problems in Women: Antecedents, Consequences, and Intervention
WILLIAM E. FANN
The Meaning of Addiction: Compulsive Experience and Its Interpretation
EUGENE F. GAURON
The Electrophysiology of Intellectual Functions
ROBERT W. MCCARLEY
Theory and Treatment of Anorexia Nervosa and Bulimia: Biomedical, Sociocultural, and Psychological Perspectives
PAULINE S. POWERS
Biofeedback and Sports Science
EUGENE F. GAURON
Neurophysiological Approaches to Higher Brain Functions
JOHN M. MORIHISA
Correction
Letters to the Editor
Clonidine therapy in withdrawal from high-dose alprazolam treatment
Bloodletting as purging behavior
Lorazepam and manic agitation
Hyponatremia associated with carbamazepine therapy
Akathisia associated with carbamazepine therapy
Carbamazepine in the treatment of tardive dyskinesia
Lithium-aggravated nocturnal myoclonus and restless legs syndrome
On Reading More and Knowing Less
MURRAY B. STEIN
Prevalence of Psychosis, Delusions, and Hallucinations in Clinical Trials With Bupropion
J. ANDREW JOHNSTON; CHARLES G. LINEBERRY; CATHY S. FRIEDEN
Prevalence of psychosis, delusions, and hallucinations in clinical trials with bupropion
Dr. Golden and Associates Reply
ROBERT N. GOLDEN; MATTHEW V. RUDORFER; WILLIAM Z. POTTER
Dr. Shafii Replies
MOHAMMAD SHAFII
Handling suicide threats in children and adolescents
Handling Suicide Threats in Children and Adolescents
JOHN S. WERRY
Dr. Donovan Replies
JAMES M. DONOVAN
The etiologic model of alcoholism
The Etiologic Model of Alcoholism
THOMAS W. HESTER
Withdrawal syndrome in a depressed patient treated with trazodone
Lorazepam for the treatment of psychotic agitation
Variations in plasma drug levels from different laboratories
Negative symptoms and cognitive deficits in schizophrenic patients
Double-blind, placebo-controlled studies of bulimic patients
Double-Blind, Placebo-Controlled Studies of Bulimic Patients
PATRICIA ROSEBUSH
Drs. Walker and Green Reply
ELAINE WALKER; MICHAEL GREEN
A Milestone for the Dexamethasone Suppression Test
STEVEN B. FRIEDENTHAL; CONRAD M. SWARTZ
Is standard deviation always the right choice?
Is Standard Deviation Always the Right Choice?
ANDREW NIERENBERG; JAMES JEKEL; BURTON SINGER
Spiritual "Mourning" and Altered Consciousness
CARL C. BELL
Spiritual "mourning" and altered consciousness
Indications for CAT scans of psychiatric patients
Dr. Griffith and Associates Reply
EZRA E.H. GRIFFITH; GEORGE MAHY; JOHN L. YOUNG
The Dexamethasone Suppression Test, Poststroke Depression, and the Validity of DSM-III-Based Diagnostic Criteria
ELLIOTT D. ROSS; WAYNE A. GORDON; MARY HIBBARD; SUSAN EGELKO
The dexamethasone suppression test, poststroke depression, and the validity of DSM-III-based diagnostic criteria
Drs. Lipsey and Robinson Reply
JOHN R. LIPSEY; ROBERT G. ROBINSON
Freud's Views on Castration
RICHARD WAUGAMAN
Drs. Jacobs and Mack Reply
DOUGLAS JACOBS; JOHN MACK
Legal liabilities of long-distance intervention
Legal Liabilities of Long-Distance Intervention
ROBERT LLOYD GOLDSTEIN
Prostaglandins and Mental Disorder
KENNETH M. LIPMAN
Posttraumatic stress disorder, partial complex seizures, and alcoholism
Prostaglandins and mental disorder
Dr. Beal Replies
DANIEL MICHAEL BEAL
  |  
Copyright ©
American
Psychiatric
Association